COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 1259: Articles 12581-12590  | Next

The importance of the population age-structure: insights from Covid-19 dynamics model structured by age, time since infection and acquired immunity
Reyne, B., Richard, Q., Nous, C., Selinger, C., Sofonea, M. T., Djidjou-Demasse, R., Alizon, S.
10.1101/2021.09.30.21264339 — Posted: 2021-10-03
Longitudinal changes and key determinants of meeting WHO recommended levels of physical activity during the COVID-19 pandemic in a UK-based sample: Findings from the HEBECO Study.
Mitchell, J. J., Dicken, S. J., Kale, D., Herbec, A., Beard, E., Shahab, L.
10.1101/2021.09.30.21264358 — Posted: 2021-10-03
COVID-19 risk factors amongst 14,786 care home residents: An observational longitudinal analysis including daily community positive test rates of COVID-19, hospital stays, and vaccination status in Wales (UK) between 1st September 2020 and 1st May 2021.
Hollinghurst, J., Hollinghurst, R., North, L., Mizen, A., Akbari, A., Long, S., Lyons, R. A., Fry, R.
10.1101/2021.09.30.21264338 — Posted: 2021-10-03
COVID-19 mortality in Italy varies by patient age, sex and pandemic wave
Minnai, F., De Bellis, G., Dragani, T. A., Colombo, F.
10.1101/2021.10.01.21264359 — Posted: 2021-10-02 Discussion: Onsite
COVID-19 in twins: What can we learn from them
Castro, M. V., Silva, M. V. R., Naslavsky, M. S., Santos, K. S., Magawa, J. Y., Cunha-Neto, E., Passos Bueno, M. R., Zatz, M.
10.1101/2021.09.29.21263145 — Posted: 2021-10-02 Discussion: Onsite
Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients
Fung, K. W., Baik, S., Baye, F., Zheng, Z., Huser, V., McDonald, C.
10.1101/2021.09.28.21264186 — Posted: 2021-10-01 Discussion: Onsite
Comparison of Plaque Size, Thermal Stability, and Replication Rate among SARS-CoV-2 Variants of Concern
Jeong, G. U., Yoon, G. Y., Moon, H. W., Lee, W., Hwang, I., Kim, H. S., Kim, K.-D., Kim, C., Ahn, D.-G., Kim, B.-T., Kim, S.-J., Kwon, Y.-C.
10.1101/2021.09.30.462687 — Posted: 2021-10-01
ZBP1 induces inflammatory signaling via RIPK3 and promotes SARS-CoV-2-induced cytokine expression
Peng, R., Wang-Kan, X., Idorn, M., Zhou, F. Y., Orozco, S. L., McCarthy, J., Leung, C. S., Lu, X., Bagola, K., Rehwinkel, J., Oberst, A., Maelfait, J., Paludan, S. R., Gyrd-Hansen, M.
10.1101/2021.10.01.462460 — Posted: 2021-10-01
COVID-19 Pandemic Response in a Migrant Farmworker Community: Excess Mortality, Testing Access and Contact Tracing in Immokalee, Florida
Limaye, N., Ninesling, B., Marcelin, F., Nolan, C., Sobba, W., Hing, M., Ptaszek, E., Leandre, F., Palazuelos, D.
10.1101/2021.10.01.21264382 — Posted: 2021-10-01
Telemedicine and molecular Sars-CoV-2 early detection to face the COVID-19 pandemic
Cherem, J., Pylro, V. S., Poles, K., Carvalho, R. C., Carvalho, E., Anacleto, J., Alvarenga, I. M., Alvarenga, D. R., Teixeira, K. d. S., Castro, J. C., Torquete, M. A., Barcante, J. M.
10.1101/2021.09.29.21264314 — Posted: 2021-10-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).